A clinical trial to study the effect of the Siddha medicine in patients having Poly cystic ovarian syndrome (PCOS)

Phase II Non randomized open clinical evaluation of Siddha medicine Thumattikkai Mezhugu for Soothaga Vaayu (PCOS)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/09/027580

Enrollment

Registered

2020-09-03

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: THUMATTIKKAI MEZHUGU: 130 mg of Thumattikkai mezhugu is administered once in a day at morning with palm jaggery for 3 days during menstrual cycle. Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: subjects within 15 - 35 years Both Unmarried and married women Amenorrhoea Irregular menstruation Oligomenorrhoea Polycystic ovary in ultra sound ( unilateral/ bilateral)

Exclusion criteria

Exclusion criteria: H/O Hypothyroidism/ Hyperthyroidism H/O Pituitary/ adrenal disorders H/O Hemorrhagic cyst H/O Chocolate cyst H/O Tuberculosis of the ovary and uterus

Design outcomes

Primary

Measure	Time frame
Primary outcome is mainly assessed by regulation of menstrual cycle regulation of ovulation disappearance / reduction in the size or number of the cystTimepoint: 3 days (3 consecutive cycles)	—

Secondary

Measure	Time frame
Secondary outcome is assessed by comparing the hormonal levels reduction in size of cyst before and after treatmentTimepoint: 3 days ( 3 consecutive cycles)	—

Countries

India

Contacts

Public ContactDr Abisha R

Government Siddha Medical college

ujjeevanam@gmail.com9884175653

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026